CIAS
AMRX icon

CBIZ Investment Advisory Services’s Amneal Pharmaceuticals AMRX Stock Holding History

CBIZ Investment Advisory Services’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$809 – 671
2025
Q2 		$809 Hold
100
– – ﹤0.01% 612
2025
Q1 		$838 Hold
100
– – ﹤0.01% 527
2024
Q4 		$792 Buy
+100
New +$839 ﹤0.01% 435

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

CBIZ Investment Advisory Services's AMRX Position: Q3 2025 in Review

CBIZ Investment Advisory Services sold out of Amneal Pharmaceuticals (AMRX) in Q3 2025, closing a stake of 100 shares — an estimated $809 sold.

CBIZ Investment Advisory Services first reported a position in AMRX in Q4 2024 and held it in 3 quarters. The position peaked at $838 in Q1 2025. 248 funds tracked by Wall St. Rank hold AMRX as of Q3 2025.

  • CBIZ Investment Advisory Services reported no remaining Amneal Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • CBIZ Investment Advisory Services sold 100 Amneal Pharmaceuticals shares in Q3 2025, an estimated $809.
  • CBIZ Investment Advisory Services first reported a position in Amneal Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • CBIZ Investment Advisory Services's Amneal Pharmaceuticals position peaked at $838 in Q1 2025.
  • 248 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2025.

Based on CBIZ Investment Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.